SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurogene to Present NGN-401 Data at ESGCT Congress

Neurogene says it will present data on its NGN-401 gene therapy program for Rett syndrome at the European Society of Gene and Cell Therapy Congress.

NGNE

Story updates

11:30:36 AM UTC
SquawkNews
New data showing rapid and durable full-length MECP2 expression in vivo with single-stranded AAV sup

Related stories